A doctor and a patient discussing a therapy plan that includes pharmaceutical products. GSK plc (NYSE:GSK), formerly known as GlaxoSmithKline, is a global pharmaceutical and healthcare corporation ...

GSK is one of the pharma industry's top vaccine producers, giving Affinivax' shot the marketing muscle it will need to challenge Pfizer's Prevnar 13 and Prevnar 20 products – targeting 13 and 20 ...

India's GlaxoSmithKline Pharma reports higher ... with Pfizer worth a combined $897 million to manufacture products for the U.S. pharmaceutical giant. May 19, 2023 Abbott's India arm posts 9.5 ...

Pfizer’s two-year run with the only 5-in-1 meningococcal vaccine on the U.S. market has come to an end. Now, GSK is ready to play catch-up after nabbing its own FDA approval. The FDA approved ...

GSK Pharma shares gained by 20 percent on Monday, February 17, as brokerages like ICICI Securities and Motilal Oswal continue to maintain positive rating of the stock. GlaxoSmithKline ...

Feb 13 (Reuters) - India's GlaxoSmithKline Pharmaceuticals (GLAX.NS), opens ... The Indian unit of British drugmaker GSK (GSK.L), opens new tab said its profit before exceptional items and tax ...

The first would be products innovated in ... Formerly known as GlaxoSmithKline, GSK plc (NYSE:GSK) is a global healthcare and pharmaceutical corporation that develops and distributes a range ...

GSk's Giant Profits This surge in company shares came to pass after the pharma giant reported a monumental rise in its profit after tax. The company's PAT rose multifold, in recently concluded ...

The shares of GlaxoSmithKline Pharmaceuticals Ltd (GSK Pharma) jumped over 15 percent to trade at Rs 2,684 apiece on February 18, extending gains for the second straight session after releasing ...

GSK, led by chief executive Emma Walmsley, has struggled with shares falling almost 20 per cent since 2022. Picture: Getty Images ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.

The United Kingdom-based pharma giant, GlaxoSmithKline Pharmaceuticals or GSK's Indian arm GSK Pharmaceuticals, saw its shares continue to rise on Tuesday as well. This is because the company made ...